Ad26.COV2.S COVID-19 vaccine safety and immunogenicity in adolescents 16-17 years of age.

IF 2.5 4区医学 Q3 INFECTIOUS DISEASES

Journal of the Pediatric Infectious Diseases Society Pub Date : 2024-09-28 DOI:10.1093/jpids/piae098

Javier Ruiz-Guiñazú, Mathieu Le Gars, Vicky Cárdenas, Nathalie Vaissière, Jerald Sadoff, Carla Truyers, Jenny Hendriks, Gert Scheper, A Marit de Groot, Frank Struyf, Hanneke Schuitemaker, Macaya Douoguih

引用次数: 0

查看原文本刊更多论文

Ad26.COV2.S COVID-19 疫苗在 16-17 岁青少年中的安全性和免疫原性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the Pediatric Infectious Diseases Society Medicine-Pediatrics, Perinatology and Child Health

CiteScore

6.70

自引率

0.00%

发文量

179

期刊介绍： The Journal of the Pediatric Infectious Diseases Society (JPIDS), the official journal of the Pediatric Infectious Diseases Society, is dedicated to perinatal, childhood, and adolescent infectious diseases. The journal is a high-quality source of original research articles, clinical trial reports, guidelines, and topical reviews, with particular attention to the interests and needs of the global pediatric infectious diseases communities.